Capoten: Clinical Trials

6 trials of Capoten, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 enrolling by invitation, 1 recruiting, 1 terminated. 3 Phase 1, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Terminated 1, Withdrawn 1
Phase 42Completed 1, Enrolling by invitation 1

Follow Capoten: new trials by email Literature Review of Capoten trials Research Report on Capoten

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes
Phase 4Enrolling by invitationBaylor Research Institute642026-04-082026-10-13
Bioequivalence Study Between Capoten Versus Captopril Reference Product in Healthy Adult Participants Under Fasting Conditions
Capoten, Captopril - Healthy Volunteers
Phase 1WithdrawnGlaxoSmithKline2022-02-132023-01-27
Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans
Captopril Tablets, Iohexol - Hormone Therapy
RecruitingUniversity of Calgary2002020-11-302025-03-27
Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery
ACEI continuation, ACEI omission - Hypotension on Induction
Phase 4CompletedUniversity of Nebraska2912015-06-012023-09-25
Contribution of Angiotensin II to Supine Hypertension in Autonomic Failure
Losartan, Captopril, Placebo - Hypertension, Pure Autonomic Failure
Phase 1TerminatedVanderbilt University122011-03-012018-08-24
Treatment of Supine Hypertension in Autonomic Failure
Clonidine, Nitroglycerin transdermal, Dipyridamole/ Aspirin (Aggrenox) - Hypertension
Phase 1CompletedVanderbilt University1522001-01-012017-10-13

Conditions studied

Hypertension (2)  ·  Multiple System Atrophy (2)  ·  Pure Autonomic Failure (2)  ·  Albuminuria (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Hyperkalemia (1)  ·  Renal Insufficiency, Chronic (1)  ·  Shy-Drager Syndrome (1)

Sponsors

Vanderbilt University (2)  ·  Baylor Research Institute (1)  ·  GlaxoSmithKline (1)  ·  University of Calgary (1)  ·  University of Nebraska (1)

Countries

United States (4)  ·  Canada (1)

Top investigators

Italo Biaggioni, MD (2)  ·  Jason F Shiffermiller, MD, MPH (1)  ·  Sofia Ahmed, MD (1)

Results publications

PMID 10851208, PMID 11927799, PMID 12119802, PMID 12923400, PMID 15738343, PMID 16391172, PMID 16533484, PMID 18426998, PMID 19047577, PMID 19738158, PMID 22801444, PMID 23266540, PMID 30261084, PMID 9369256, PMID 9890307